Old Web
English
Sign In
Acemap
>
Paper
>
RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial
RE: Expected Monetary Impact of Oncotype DX Score-Concordant Systemic Breast Cancer Therapy Based on the TAILORx Trial
2019
Paolo Giorgi-Rossi
Eugenio Paci
Keywords:
Immunology
Breast cancer
Oncotype DX
Internal medicine
Biology
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
4
References
2
Citations
NaN
KQI
[]